Denali Therapeutics Inc. - DNLI

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 23
Latest filed: Jul 08, 2026
Form Count
8-K 8
4 8
SCHEDULE 13G/A 3
144 3
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Jul 08, 2026 SCHEDULE 13G/A 0001897612-26-000525 View
Jun 18, 2026 8-K Jun 12, 2026 0001714899-26-000081 View
Jun 05, 2026 4 Jun 03, 2026 0001478007-26-000002 View
Jun 05, 2026 4 Jun 03, 2026 0001666236-26-000015 View
Jun 05, 2026 4 Jun 03, 2026 0001578200-26-000004 View
Jun 05, 2026 4 Jun 03, 2026 0001189130-26-000005 View
Jun 05, 2026 4 Jun 03, 2026 0001193125-26-259680 View
Jun 05, 2026 4 Jun 03, 2026 0001754371-26-000002 View
Jun 05, 2026 4 Jun 03, 2026 0001797826-26-000002 View
Jun 05, 2026 4 Jun 03, 2026 0001816206-26-000003 View
Jun 04, 2026 8-K Jun 03, 2026 0001714899-26-000074 View
May 22, 2026 8-K May 21, 2026 0001714899-26-000070 View
May 15, 2026 SCHEDULE 13G 0001897612-26-000486 View
May 07, 2026 8-K May 07, 2026 0001714899-26-000062 View
May 06, 2026 SCHEDULE 13G/A 0000315066-26-001172 View
Apr 03, 2026 8-K Apr 03, 2026 0001714899-26-000042 View
Mar 31, 2026 8-K Mar 27, 2026 0001714899-26-000036 View
Mar 26, 2026 SCHEDULE 13G/A 0000102909-26-001186 View
Mar 25, 2026 8-K Mar 25, 2026 0001714899-26-000030 View
Feb 26, 2026 8-K Feb 26, 2026 0001714899-26-000020 View
Feb 05, 2026 144 0001950047-26-000957 View
Feb 04, 2026 144 0001950047-26-000923 View
Feb 03, 2026 144 0001950047-26-000895 View